Oral Bioavailability Innovations
For dietary supplements, herbs and other nutrients in which the route of
administration is nearly always oral, bioavailability generally designates simply the quantity or fraction of the ingested dose that is absorbed.In nutritional sciences, which covers the intake of nutrients and non-drug dietary ingredients, the concept of bioavailability lacks the well-defined standards associated with the pharmaceutical industry. The pharmacological definition cannot apply to these substances because utilization and absorption is a function of the nutritional status and physiological state of the subject, resulting in even greater differences from individual to individual (inter-individual variation). Therefore, bioavailability for dietary supplements can be defined as the proportion of the administered substance capable of being absorbed and available for use or storage.In both
pharmacology and
nutrition sciences, bioavailability is measured by calculating the area under curve (AUC) of the drug concentration time profile.In pharmacology, so as to decide outright bioavailability of a medication, a
pharmacokinetic study must be done to get a plasma sedate fixation versus time plot for the medication after both intravenous (iv) and extravascular (non-intravenous, i.e., oral) organization. The total bioavailability is the portion remedied region under bend (AUC) non-intravenous separated by AUC intravenous. The equation for computing the supreme bioavailability, F, of a medication managed orally (po) is given underneath (where D is portion directed
High Impact List of Articles
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
The next generation of trial design innovation: strategies, methods and logistical considerations for flexible trial designs
Terry L Katz, Sandeep Menon
Conference Report: Clinical Investigation
-
The next generation of trial design innovation: strategies, methods and logistical considerations for flexible trial designs
Terry L Katz, Sandeep Menon
Conference Report: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Javier Rueda, Miguel A Gonzlez-Gay, Ricardo Blanco
Review Article: Clinical Investigation
-
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Javier Rueda, Miguel A Gonzlez-Gay, Ricardo Blanco
Review Article: Clinical Investigation
Relevant Topics in Clinical